BRPI0912021A2 - composição padronizada, método de fabricação e uso na resolução de infecção por vírus de rna - Google Patents

composição padronizada, método de fabricação e uso na resolução de infecção por vírus de rna

Info

Publication number
BRPI0912021A2
BRPI0912021A2 BRPI0912021A BRPI0912021A BRPI0912021A2 BR PI0912021 A2 BRPI0912021 A2 BR PI0912021A2 BR PI0912021 A BRPI0912021 A BR PI0912021A BR PI0912021 A BRPI0912021 A BR PI0912021A BR PI0912021 A2 BRPI0912021 A2 BR PI0912021A2
Authority
BR
Brazil
Prior art keywords
manufacture
virus infection
rna virus
standardized composition
resolving
Prior art date
Application number
BRPI0912021A
Other languages
English (en)
Inventor
Bhaskaran Sunil
Vishwaraman Mohan
Original Assignee
Indus Biotech Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indus Biotech Private Ltd filed Critical Indus Biotech Private Ltd
Publication of BRPI0912021A2 publication Critical patent/BRPI0912021A2/pt
Publication of BRPI0912021B1 publication Critical patent/BRPI0912021B1/pt
Publication of BRPI0912021B8 publication Critical patent/BRPI0912021B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
BRPI0912021A 2009-08-11 2009-09-23 composição padronizada, método de fabricação e uso na resolução de infecção por vírus de rna BRPI0912021B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1857MU2009 2009-08-11
IN01857/MUM/2009 2009-08-11
PCT/IN2009/000519 WO2011018793A1 (en) 2009-08-11 2009-09-23 A novel standardized composition, method of manufacture and use in the resolution of rna virus infection

Publications (3)

Publication Number Publication Date
BRPI0912021A2 true BRPI0912021A2 (pt) 2015-10-06
BRPI0912021B1 BRPI0912021B1 (pt) 2020-03-24
BRPI0912021B8 BRPI0912021B8 (pt) 2021-05-25

Family

ID=43586001

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0912021A BRPI0912021B8 (pt) 2009-08-11 2009-09-23 composição padronizada, método de fabricação e uso na resolução de infecção por vírus de rna

Country Status (11)

Country Link
US (1) US8835415B2 (pt)
EP (1) EP2328575B1 (pt)
JP (1) JP5369320B2 (pt)
KR (1) KR101323491B1 (pt)
CN (1) CN102099028B (pt)
AU (1) AU2009347566B2 (pt)
BR (1) BRPI0912021B8 (pt)
CA (1) CA2721040C (pt)
ES (1) ES2529705T3 (pt)
RU (1) RU2472502C2 (pt)
WO (1) WO2011018793A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2900614T3 (es) * 2010-07-28 2022-03-17 Indus Biotech Private Ltd Método de gestión de una afección broncoconstrictiva
WO2013011458A1 (en) 2011-07-19 2013-01-24 Indus Biotech Private Limited A method of managing chemotherapy induced alopecia or cachexia or both
EP2882434B1 (en) * 2012-08-07 2018-08-08 Indus Biotech Private Limited A method of managing diabetic foot ulcers, pressure ulcers, venous leg ulcers and associated complication
BR112015028983A2 (pt) 2013-05-20 2017-07-25 Indus Biotech Private Ltd método para controlar fibrose hepática, vírus da hepatite c e afecção associada
JP2015214501A (ja) * 2014-05-08 2015-12-03 株式会社ニッピ ウイルスの細胞内増殖抑制剤、Ｍｎ−ＳＯＤ活性化剤および抗ウイルス剤
CN106606539B (zh) * 2016-12-16 2019-07-23 昆药集团股份有限公司 一种肉桂多酚组合物的应用
KR102247702B1 (ko) * 2017-01-11 2021-05-03 주식회사 종근당 위염 또는 소화성궤양 예방 또는 치료용 조성물
JP7381251B2 (ja) * 2019-08-23 2023-11-15 セッツ株式会社 抗ノロウイルス剤、消毒剤及び洗浄剤
WO2022123513A1 (en) * 2020-12-10 2022-06-16 Indus Biotech Private Limited Composition and method for managing coronavirus infection
CA3239975A1 (en) * 2021-12-07 2023-06-15 Pm Group Company Limited Compositions comprising dimocarpus extract for use in the treatment or prevention of an infection caused by an enveloped virus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297273B1 (en) * 1996-04-02 2001-10-02 Mars, Inc. Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
AU2001253294A1 (en) * 2000-04-14 2001-10-30 Mars, Incorporated Compositions and methods for improving vascular health
US6960360B2 (en) * 2000-08-31 2005-11-01 Phenolics, Llc Efficient method for producing compositions enriched in total phenols
CN1758917A (zh) * 2002-12-02 2006-04-12 马尔斯公司 黄烷醇和矢车菊苷配质促进内环境稳定
EP1569670A4 (en) * 2002-12-02 2008-10-15 Mars Inc FLAVANOLS AND PROCYANIDES FOR PROMOTING HOMEOSTASIS
JP4691028B2 (ja) * 2003-07-17 2011-06-01 ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウマ結合型エストロゲン天然混合物を得るための方法
JPWO2005030200A1 (ja) * 2003-09-26 2006-12-07 麒麟麦酒株式会社 自己免疫疾患治療剤
US7879342B2 (en) * 2004-03-12 2011-02-01 Univ. Of Georgia Research Foundation, Inc. Vaccine adjuvant and making and using the same

Also Published As

Publication number Publication date
CN102099028A (zh) 2011-06-15
RU2010148919A (ru) 2012-06-10
KR20110070963A (ko) 2011-06-27
WO2011018793A1 (en) 2011-02-17
JP5369320B2 (ja) 2013-12-18
ES2529705T3 (es) 2015-02-24
AU2009347566B2 (en) 2012-05-31
CA2721040C (en) 2016-08-02
US20110039923A1 (en) 2011-02-17
BRPI0912021B1 (pt) 2020-03-24
EP2328575B1 (en) 2014-11-12
RU2472502C2 (ru) 2013-01-20
EP2328575A1 (en) 2011-06-08
KR101323491B1 (ko) 2013-10-31
US8835415B2 (en) 2014-09-16
CN102099028B (zh) 2013-09-25
CA2721040A1 (en) 2011-02-11
AU2009347566A1 (en) 2011-03-03
JP2011530609A (ja) 2011-12-22
EP2328575A4 (en) 2012-10-17
BRPI0912021B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
BRPI0912021A2 (pt) composição padronizada, método de fabricação e uso na resolução de infecção por vírus de rna
BR112012002331A2 (pt) composição antiviral, composição farmacêutica e uso de quantidade efetiva de composição farmacêutica
BRPI0924622A2 (pt) composições para tratamento de tecidos, processo de fabricação, e método de uso.
BRPI0924427A2 (pt) composição farmacêutica de liberação controlada, seu processo de preparação e uso da mesma
BRPI0911594A2 (pt) di-hidropirazolonas substistuídas, seu processo de preparação e seu uso, bem como medicamentos
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI1010774A2 (pt) método de uso de particulados.
BR112012033538A2 (pt) linhagem celular imortalizada e método de replicação de um vírus
BR112012001978A2 (pt) filtro e método de preparação do filtro
BRPI0819971A2 (pt) anticorpos contra vírus influenza e métodos de seu uso
BR112012022878A2 (pt) composto, composição farmacêutica, uso do compostos e método de tratamento
BRPI0920263A2 (pt) composto, uso do composto, composição, e, método
BR112012010396A2 (pt) seringa de ar, água e vácuo e método de uso
BRPI1007477A2 (pt) método, e, composição de tratamento de poço
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
BRPI0813140A2 (pt) Composição, método e preparação de ácido biliar sintético
BR112012006404A2 (pt) derivados de di-hidropteridinona, processo de preparação e uso farmacêutico dos mesmos
BR112012005321A2 (pt) processo e composição
BRPI0911815A2 (pt) estrutura de multifilme, estrutura de envelope feita de uma estrutura de multifilme, uso de uma estrutura de multifilme e processo para preparar uma estrutura de multifilme
BRPI0814420A2 (pt) composição, e, uso de álcool alcoxilado.
BR112012003148A2 (pt) composição de remoção de oxigênio, artigo,e, uso da composição de remoção de oxigênio
BRPI1016076A2 (pt) composições antiodor e método de uso para neutralizar o mau cheiro do suor.
BRPI1006996A2 (pt) composição, método e uso
BR112012007898A2 (pt) aduto de amina-epóxi, seu processo de preparação e seu uso
BR112012005349A2 (pt) composição imunogênica, seu método de fabricação, método de fabricação de uma composição de vacina de matriz de proteína, e uso

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/03/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/09/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF